Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

The status of HBV infection influences metastatic pattern and survival in Chinese patients with pancreatic cancer.

Wei XL, Qiu MZ, Chen WW, Jin Y, Ren C, Wang F, Luo HY, Wang ZQ, Zhang DS, Wang FH, Li YH, Xu RH.

J Transl Med. 2013 Oct 8;11:249. doi: 10.1186/1479-5876-11-249.

2.

Chronic hepatitis B virus infection in Asian countries.

Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, Hasnian SS, Leung N, Lesmana L, Phiet PH, Sjalfoellah Noer HM, Sollano J, Sun HS, Xu DZ.

J Gastroenterol Hepatol. 2000 Dec;15(12):1356-61. Review.

PMID:
11197043
3.

HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma.

Yuen MF, Wong DK, Fung J, Ip P, But D, Hung I, Lau K, Yuen JC, Lai CL.

Gastroenterology. 2008 Oct;135(4):1192-9. doi: 10.1053/j.gastro.2008.07.008. Epub 2008 Jul 16.

PMID:
18722377
4.

Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis C.

Squadrito G, Cacciola I, Alibrandi A, Pollicino T, Raimondo G.

J Hepatol. 2013 Oct;59(4):696-700. doi: 10.1016/j.jhep.2013.05.043. Epub 2013 Jun 7. Erratum in: J Hepatol. 2014 Jan;60(1):238.

PMID:
23751755
5.

Prognostic value of chronic hepatitis B virus infection in patients with nasopharyngeal carcinoma: analysis of 1301 patients from an endemic area in China.

Liu X, Li X, Jiang N, Lei Y, Tang LL, Chen L, Zhou GQ, Sun Y, Yue D, Guo R, Mao YP, Li WF, Liu LZ, Tian L, Lin AH, Ma J.

Cancer. 2014 Jan 1;120(1):68-76. doi: 10.1002/cncr.28377. Epub 2013 Sep 24.

6.

Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant.

Hsu HY, Chang MH, Ni YH, Jeng YM, Chiang CL, Chen HL, Wu JF, Chen PJ.

J Infect Dis. 2013 Apr;207(7):1047-57. doi: 10.1093/infdis/jis943. Epub 2013 Jan 8.

PMID:
23300165
7.

[The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma].

Pei YZ, Han T, Ma XY, Li Y, Xing J, Song ZL.

Zhonghua Gan Zang Bing Za Zhi. 2011 Oct;19(10):743-6. doi: 10.3760/cma.j.issn.1007-3418.2011.10.006. Chinese.

PMID:
22409845
8.

Reactivation of hepatitis B virus infection in pancreatic cancer: a case report.

Oksüzoğlu B, Kiliçkap S, Yalcin S.

Jpn J Clin Oncol. 2002 Dec;32(12):543-5.

PMID:
12578904
9.

Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.

Jang JS, Kim HS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Kim DJ, Lee MS, Park CK, Jeong BH, Kim YS, Jang MK.

J Med Virol. 2009 Sep;81(9):1531-8. doi: 10.1002/jmv.21577.

PMID:
19623669
10.

Risk of pancreatic cancer in chronic hepatitis B virus infection: data from the REVEAL-HBV cohort study.

Iloeje UH, Yang HI, Jen CL, Su J, Wang LY, You SL, Lu SN, Chen CJ.

Liver Int. 2010 Mar;30(3):423-9. doi: 10.1111/j.1478-3231.2009.02147.x. Epub 2009 Oct 16.

PMID:
19840258
11.

Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.

Manesis EK, Papatheodoridis GV, Tiniakos DG, Hadziyannis ES, Agelopoulou OP, Syminelaki T, Papaioannou C, Nastos T, Karayiannis P.

J Hepatol. 2011 Jul;55(1):61-8. doi: 10.1016/j.jhep.2010.10.027. Epub 2010 Dec 5.

PMID:
21145875
12.

Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.

Shim J, Kim BH, Kim NH, Dong SH, Kim HJ, Chang YW, Lee JI, Chang R.

J Gastroenterol Hepatol. 2005 May;20(5):746-51.

PMID:
15853989
13.

HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.

Momosaki S, Nakashima Y, Kojiro M, Tabor E.

J Viral Hepat. 2005 May;12(3):325-9.

PMID:
15850475
14.

HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects.

Yuen MF, Wong DK, Sablon E, Tse E, Ng IO, Yuan HJ, Siu CW, Sander TJ, Bourne EJ, Hall JG, Condreay LD, Lai CL.

Hepatology. 2004 Jun;39(6):1694-701. Erratum in: Hepatology. 2004 Sep;40(3):767.

PMID:
15185311
16.

The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection.

Zerbini A, Pilli M, Boni C, Fisicaro P, Penna A, Di Vincenzo P, Giuberti T, Orlandini A, Raffa G, Pollicino T, Raimondo G, Ferrari C, Missale G.

Gastroenterology. 2008 May;134(5):1470-81. doi: 10.1053/j.gastro.2008.02.017. Epub 2008 Feb 14.

PMID:
18355815
17.
18.

Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.

Martinot-Peignoux M, Lapalus M, Laouénan C, Lada O, Netto-Cardoso AC, Boyer N, Ripault MP, Carvalho-Filho R, Asselah T, Marcellin P.

J Clin Virol. 2013 Oct;58(2):401-7. doi: 10.1016/j.jcv.2013.08.010. Epub 2013 Aug 16.

PMID:
24004660
19.

The change of the quantitative HBsAg level during the natural course of chronic hepatitis B.

Kim YJ, Cho HC, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW.

Liver Int. 2011 Jul;31(6):817-23. doi: 10.1111/j.1478-3231.2011.02516.x. Epub 2011 Mar 22.

PMID:
21645212
20.

Profile, spectrum and significance of hepatitis B virus genotypes in chronic HBV-infected patients in Yunnan, China.

You J, Sriplung H, Chongsuvivatwong V, Geater A, Zhuang L, Huang JH, Chen HY, Yu L, Tang BZ.

Hepatobiliary Pancreat Dis Int. 2008 Jun;7(3):271-9.

PMID:
18522881

Supplemental Content

Support Center